Standard
Bile salt enhancers for inhalation : Correlation between in vitro and in vivo lung effects. / Sorli, Jorid B.; Sivars, Kinga Balogh; Da Silva, Emilie; Hougaard, Karin S.; Koponen, Ismo K.; Zuo, Yi Y.; Weydahl, Ingrid E. K.; Aberg, Per M.; Fransson, Rebecca.
In:
International Journal of Pharmaceutics, Vol. 550, No. 1-2, 2018, p. 114-122.
Research output: Contribution to journal › Journal article › peer-review
Harvard
Sorli, JB, Sivars, KB, Da Silva, E, Hougaard, KS, Koponen, IK, Zuo, YY, Weydahl, IEK, Aberg, PM & Fransson, R 2018, '
Bile salt enhancers for inhalation: Correlation between in vitro and in vivo lung effects',
International Journal of Pharmaceutics, vol. 550, no. 1-2, pp. 114-122.
https://doi.org/10.1016/j.ijpharm.2018.08.031
APA
Sorli, J. B., Sivars, K. B., Da Silva, E., Hougaard, K. S., Koponen, I. K., Zuo, Y. Y., Weydahl, I. E. K., Aberg, P. M., & Fransson, R. (2018).
Bile salt enhancers for inhalation: Correlation between in vitro and in vivo lung effects.
International Journal of Pharmaceutics,
550(1-2), 114-122.
https://doi.org/10.1016/j.ijpharm.2018.08.031
Vancouver
Sorli JB, Sivars KB, Da Silva E, Hougaard KS, Koponen IK, Zuo YY et al.
Bile salt enhancers for inhalation: Correlation between in vitro and in vivo lung effects.
International Journal of Pharmaceutics. 2018;550(1-2):114-122.
https://doi.org/10.1016/j.ijpharm.2018.08.031
Author
Sorli, Jorid B. ; Sivars, Kinga Balogh ; Da Silva, Emilie ; Hougaard, Karin S. ; Koponen, Ismo K. ; Zuo, Yi Y. ; Weydahl, Ingrid E. K. ; Aberg, Per M. ; Fransson, Rebecca. / Bile salt enhancers for inhalation : Correlation between in vitro and in vivo lung effects. In: International Journal of Pharmaceutics. 2018 ; Vol. 550, No. 1-2. pp. 114-122.
Bibtex
@article{53426f63882747fcb107fa1e692f5146,
title = "Bile salt enhancers for inhalation: Correlation between in vitro and in vivo lung effects",
keywords = "Lung surfactant, Constrained drop surfactometer, Inhaled pharmaceutical enhancer, Bile salt, 3D human airway in vitro model, MucilAir (TM), Alternative method",
author = "Sorli, {Jorid B.} and Sivars, {Kinga Balogh} and {Da Silva}, Emilie and Hougaard, {Karin S.} and Koponen, {Ismo K.} and Zuo, {Yi Y.} and Weydahl, {Ingrid E. K.} and Aberg, {Per M.} and Rebecca Fransson",
year = "2018",
doi = "10.1016/j.ijpharm.2018.08.031",
language = "English",
volume = "550",
pages = "114--122",
journal = "International Journal of Pharmaceutics",
issn = "0378-5173",
publisher = "Elsevier",
number = "1-2",
}
RIS
TY - JOUR
T1 - Bile salt enhancers for inhalation
T2 - Correlation between in vitro and in vivo lung effects
AU - Sorli, Jorid B.
AU - Sivars, Kinga Balogh
AU - Da Silva, Emilie
AU - Hougaard, Karin S.
AU - Koponen, Ismo K.
AU - Zuo, Yi Y.
AU - Weydahl, Ingrid E. K.
AU - Aberg, Per M.
AU - Fransson, Rebecca
PY - 2018
Y1 - 2018
KW - Lung surfactant
KW - Constrained drop surfactometer
KW - Inhaled pharmaceutical enhancer
KW - Bile salt
KW - 3D human airway in vitro model
KW - MucilAir (TM)
KW - Alternative method
U2 - 10.1016/j.ijpharm.2018.08.031
DO - 10.1016/j.ijpharm.2018.08.031
M3 - Journal article
C2 - 30125651
VL - 550
SP - 114
EP - 122
JO - International Journal of Pharmaceutics
JF - International Journal of Pharmaceutics
SN - 0378-5173
IS - 1-2
ER -